Advertisement
Our latest volumes and outcomes data in these areas plus HOCM and pericarditis
Below we share recent volumes and clinical outcomes from a sampling of disciplines and subspecialty areas in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute: thoracic surgery, lung transplantation, hypertrophic obstructive cardiomyopathy and pericarditis.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Number of general thoracic operations performed
Number of robotically assisted thoracic surgery procedures
Proportion of all lobectomies for stage I lung cancer (N = 120) that used video/robot-assisted thoracoscopic surgery
Proportion of thymectomy/thymic mass resections completed robotically (N = 33)
The following data and ratings are from the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (3-year period ending December 2023):
Total lung transplants performed, including 1 heart/lung and 5 lung/liver
Lung transplants performed after ex vivo lung perfusion (EVLP)
30-day survival rate following EVLP lung transplant
Outpatient visits for HOCM
New HOCM patients seen
Septal myectomy procedures (with or without other procedures) performed for HOCM
Observed-to-expected mortality ratio for septal myectomy*
Patients seen by our Pericardial Diseases Center
New patients seen by the Pericardial Diseases Center
Pericardial procedures performed
Pericardiectomies performed
Cleveland Clinic’s Heart, Vascular & Thoracic Institute has a long-established tradition of reporting volume and outcomes data across its various subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.
Advertisement
Advertisement
Avoidance of septal reduction therapy continues while LVEF dysfunction remains infrequent
Study finds important discrepancies among modalities and techniques
Serial strain assessments show sustained favorable impacts on LV systolic function and LA function
Exploring the cost-effectiveness of end-of-life treatment options
Offers recommendations on imaging and treatment across five clinical pericardial syndromes
The agent-based model aims to improve prediction accuracy
Logistic feasibility supported for treating obstructive HCM under the REMS program
New research aims to improve suboptimal lung transplant outcomes by “looking beyond the walls of hospitals”